Drugs / Human platelet extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05457491 | Oct 2021 → Jul 2022 | skin atrophy | Mayo Clinic | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human platelet extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05457491 ↗ |
| Known as | HPE | “Human platelet extract (HPE)” NCT05457491 ↗ |
| Route | Topical | “Applied to face twice daily for 12 weeks.” NCT05457491 ↗ |